SS
REVB icon

SBI Securities’s Revelation Biosciences REVB Stock Holding History

SBI Securities’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354 Hold
344
– – ﹤0.01% 3154
2026
Q1 		$413 Buy
344
+229
+199% +$443 ﹤0.01% 2963
2025
Q4 		$366 Hold
115
– – ﹤0.01% 2986
2025
Q3 		$650 Sell
115
-1
-0.9% -$10 ﹤0.01% 2869
2025
Q2 		$1.04K Buy
116
+72
+164% +$1.88K ﹤0.01% 2661
2025
Q1 		$1.38K Buy
44
+42
+2,100% +$2.35K ﹤0.01% 2451
2024
Q4 		$139 Buy
+2
New +$266 ﹤0.01% 3359

Other funds holding REVB

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

SBI Securities's REVB Position: Q2 2026 in Review

SBI Securities held its Revelation Biosciences (REVB) position steady in Q2 2026 at 344 shares worth $354. The position accounts for ﹤0.01% of the portfolio, ranked #3154.

SBI Securities first reported a position in REVB in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.38K in Q1 2025. 12 funds tracked by Wall St. Rank hold REVB as of Q2 2026.

  • SBI Securities held 344 shares of Revelation Biosciences worth $354 as of Q2 2026.
  • SBI Securities left its Revelation Biosciences share count unchanged in Q2 2026.
  • Revelation Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3154 holding.
  • SBI Securities first reported a position in Revelation Biosciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Revelation Biosciences position peaked at $1.38K in Q1 2025.
  • 12 funds tracked by Wall St. Rank held Revelation Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.